Stand Up to Cancer

NEW YORK (GenomeWeb News) –The fundraising organization Stand Up To Cancer (SU2C) has provided a grant of €6 million ($8.1 million) to investigators at the Dutch Cancer Society and the American Association for Cancer Research to fund an effort to grow and study living tumors from patient samples

NEW YORK (GenomeWeb News) – A multi-organization initiative has been created with the goal of discovering new therapies for childhood cancers using genomics as well as immunotherapeutic technologies.

NEW YORK (GenomeWeb News) – The Prostate Cancer Foundation plans to use a $7 million donation from New York billionaire Stewart Rahr to fund a multi-partner research project that will use genomic medicine and other approaches to discover new prostate cancer treatments.

NEW YORK (GenomeWeb News) – A second Dream Team project has been created for translational research into prostate cancer with $10 million in funding over three years.

NEW YORK (GenomeWeb News) – A group of Dutch-led research partners will use a €1.2 million ($1.5 million) grant awarded under a collaboration with Stand Up 2 Cancer (SU2C) to fund a genomics-based project seeking to use tumor profiles to predict patient response to cancer treatments.

The multi-partner non-profit cancer research initiative has funded new high-risk, high-reward grants using exome sequencing, genomic analysis, and tumor-specific drug response studies.

These high-risk awards for young scientists will support epigenomics, molecular profiling, and other studies that could be "game-changers."

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.